AbbVie has agreed to pay $65 million on an option deal with start-up Gilgamesh Pharma, lining up rights to neuroplastogen compounds that can improve neuroplasticity - the ability of the brain to ...
In Power and Progress, Daron Acemoglu and Simon Johnson revisit the Epic of Gilgamesh to illustrate a timeless dilemma: technological and institutional advances do not automatically serve the public ...
AT ONE OF the earliest points of our recorded history, the remarkable culture of Mesopotamia flourished, and one of its many versatile and precocious achievements was Gilgamesh, our first recognisable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback